The Endocannabinoid System, Cannabis, and Cannabidiol: Implications in Urology and Men's Health

Overview

Journal Curr Urol

Specialty Urology

Date 2021 Jun 25

PMID 34168527

Citations 4

Authors

Jillian L Capodice

Steven A Kaplan

Affiliations

Soon will be listed here.

Abstract

Background: The endocannabinoid system is a neuromodulatory system responsible for partial regulation of cognitive and emotional processes in the human central nervous system such as behavior, mood disorders, and neurologic disorders such as epilepsy. The endocannabinoid system is also prevalent throughout the peripheral nervous system and human body and its receptors and signaling pathways are present and active in areas including the male and female reproductive tracts and organ systems such as the urologic and gastrointestinal system.

Summary: The purpose of this article is to provide the reader with a brief background on the endocannabinoid system and to discuss the implications of the endocannabinoid system in urology as it applies to the male reproductive system, risk of urologic malignancy, and impact on the lower urinary tract, voiding, and urologic pain. It also summaries and discusses the epidemiology and research on cannabis and cannabidiol products.

Key Message: The endocannabinoid system affects the urologic and reproductive systems. Cannabis products and inhibitors targeting endocannabinoid pathways are being studied for their potential use as treatments for lower urinary tract symptoms and other urologic symptoms. Cannabis use adversely affects spermatogenesis and semen parameters and may be a risk factor for testicular germ cell tumors, however, it may be useful as a potential treatment for urologic symptoms. Cannabidiol products are popular in the consumer marketplace but there is still a paucity of scientific data on their potential medicinal use.

Citing Articles

Medicinal Cannabis and the Intestinal Microbiome.

Vitetta L, Nation T, Oldfield D, Thomsen M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770543 PMC: 11678570. DOI: 10.3390/ph17121702.

A Comparative Analysis on the Potential Anticancer Properties of Tetrahydrocannabinol, Cannabidiol, and Tetrahydrocannabivarin Compounds Through In Silico Approach.

Gallardo A, Gutierrez M, Gomez L, Delos Reyes P, Dones S, Dumbrique M Asian Pac J Cancer Prev. 2024; 25(3):839-856.

PMID: 38546067 PMC: 11152392. DOI: 10.31557/APJCP.2024.25.3.839.

Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment.

Kowalski S, Karska J, Tota M, Skinderowicz K, Kulbacka J, Drag-Zalesinska M Molecules. 2024; 29(3).

PMID: 38338469 PMC: 10856721. DOI: 10.3390/molecules29030728.

Cannabis use and binge eating: Examining the relationship between cannabis use and clinical severity among adults with binge eating.

Wilkinson M, Trainor C, Lampe E, Presseller E, Juarascio A Exp Clin Psychopharmacol. 2024; 32(4):392-397.

PMID: 38236224 PMC: 11253108. DOI: 10.1037/pha0000706.

The Effect of Marijuana on the Incidence and Evolution of Male Infertility: A Systematic Review.

Srinivasan M, Hamouda R, Ambedkar B, Arzoun H, Sahib I, Fondeur J Cureus. 2022; 13(12):e20119.

PMID: 34984155 PMC: 8720305. DOI: 10.7759/cureus.20119.

References

Banerjee A, Singh A, Srivastava P, Turner H, Krishna A . Effects of chronic bhang (cannabis) administration on the reproductive system of male mice. Birth Defects Res B Dev Reprod Toxicol. 2011; 92(3):195-205. DOI: 10.1002/bdrb.20295. View

Degenhardt L, Ferrari A, Calabria B, Hall W, Norman R, McGrath J . The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One. 2013; 8(10):e76635. PMC: 3811989. DOI: 10.1371/journal.pone.0076635. View

Brady C, Dasgupta R, Dalton C, Wiseman O, Berkley K, Fowler C . An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler. 2004; 10(4):425-33. DOI: 10.1191/1352458504ms1063oa. View

Hryciw D, McAinch A . Cannabinoid receptors in the kidney. Curr Opin Nephrol Hypertens. 2016; 25(5):459-64. DOI: 10.1097/MNH.0000000000000249. View

Laprairie R, Bagher A, Kelly M, Denovan-Wright E . Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015; 172(20):4790-805. PMC: 4621983. DOI: 10.1111/bph.13250. View

Steiner M, Marsicano G, Nestler E, Holsboer F, Lutz B, Wotjak C . Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology. 2007; 33(1):54-67. PMC: 2267923. DOI: 10.1016/j.psyneuen.2007.09.008. View

Chacko J, Heiner J, Siu W, Macy M, Terris M . Association between marijuana use and transitional cell carcinoma. Urology. 2006; 67(1):100-4. DOI: 10.1016/j.urology.2005.07.005. View

Herkenham M, Lynn A, Johnson M, Melvin L, De Costa B, Rice K . Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991; 11(2):563-83. PMC: 6575215. View

Blankman J, Cravatt B . Chemical probes of endocannabinoid metabolism. Pharmacol Rev. 2013; 65(2):849-71. PMC: 3639726. DOI: 10.1124/pr.112.006387. View

10.

Dmitrieva N, Nagabukuro H, Resuehr D, Zhang G, McAllister S, McGinty K . Endocannabinoid involvement in endometriosis. Pain. 2010; 151(3):703-710. PMC: 2972363. DOI: 10.1016/j.pain.2010.08.037. View

11.

Matsuda L, Lolait S, Brownstein M, Young A, Bonner T . Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346(6284):561-4. DOI: 10.1038/346561a0. View

12.

Bakali E, Elliott R, Taylor A, Willets J, Konje J, Tincello D . Distribution and function of the endocannabinoid system in the rat and human bladder. Int Urogynecol J. 2012; 24(5):855-63. DOI: 10.1007/s00192-012-1954-1. View

13.

Rajanahally S, Raheem O, Rogers M, Brisbane W, Ostrowski K, Lendvay T . The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review. Andrology. 2019; 7(2):139-147. DOI: 10.1111/andr.12585. View

14.

Freeman R, Adekanmi O, Waterfield M, Waterfield A, Wright D, Zajicek J . The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17(6):636-41. DOI: 10.1007/s00192-006-0086-x. View

15.

Pacey A, Povey A, Clyma J, McNamee R, Moore H, Baillie H . Modifiable and non-modifiable risk factors for poor sperm morphology. Hum Reprod. 2014; 29(8):1629-36. DOI: 10.1093/humrep/deu116. View

16.

Francavilla F, Battista N, Barbonetti A, Vassallo M, Rapino C, Antonangelo C . Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. Endocrinology. 2009; 150(10):4692-700. DOI: 10.1210/en.2009-0057. View

17.

Uckert S, la Croce G, Bettiga A, Albrecht K, Buono R, Benigni F . Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesicles. Andrologia. 2017; 50(2). DOI: 10.1111/and.12875. View

18.

Rossato M, Ion Popa F, Ferigo M, Clari G, Foresta C . Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab. 2004; 90(2):984-91. DOI: 10.1210/jc.2004-1287. View

19.

Chye Y, Christensen E, Solowij N, Yucel M . The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder. Front Psychiatry. 2019; 10:63. PMC: 6390812. DOI: 10.3389/fpsyt.2019.00063. View

20.

Cobellis G, Cacciola G, Scarpa D, Meccariello R, Chianese R, Franzoni M . Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. Biol Reprod. 2006; 75(1):82-9. DOI: 10.1095/biolreprod.106.051730. View